⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16648524 | 0.78 | — | — | |
| SCHEMBL183235 | 0.73 | — | — | |
| SCHEMBL9301830 | 0.73 | — | — | |
| SCHEMBL6744718 | 0.70 | MEN1 (0.36) | — | |
| SCHEMBL4461564 | 0.70 | — | — | |
| SCHEMBL11035730 | 0.70 | MEN1 (0.36) | — | |
| SCHEMBL4406218 | 0.70 | MEN1 (0.36) | — | |
| Iodide SCHEMBL4466392 | 0.70 | — | — | |
| SCHEMBL10021010 | 0.70 | MEN1 (0.36) | — | |
| SCHEMBL11033422 | 0.70 | MEN1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7612033-B2 | Methods for delivering compounds into a cell | IMARX PHARMACEUTICAL CORP. (US) | 2009-11-03 | — | — | US | disclosed |
| EP-0935415-B1 | IN VITRO METHODS FOR DELIVERING NUCLEIC ACIDS INTO A CELL | IMARX PHARMACEUTICAL CORP (US) | 2006-11-22 | — | — | EP | disclosed |
| US-20050080029-A1 | Methods for delivering compounds into a cell | IMARX PHARMACEUTICAL CORPORATION (US) | 2005-04-14 | — | — | US | disclosed |
| US-20040176473-A1 | Methods for delivering compounds into a cell | IMARX PHARMACEUTICAL CORP. | 2004-09-09 | — | — | US | disclosed |
| US-6743779-B1 | NUCLEIC ACID SEQUENCE AND A FLUORINATED COMPOUND AND A LIPID CARRIER. | IMARX PHARMACEUTICAL CORP. | 2004-06-01 | — | — | US | disclosed |
| US-6638767-B2 | Mixture containing organic halide | IMARX PHARMACEUTICAL CORPORATION | 2003-10-28 | — | — | US | disclosed |
| EP-0935415-A4 | METHODS FOR DELIVERING COMPOUNDS INTO A CELL | IMARX PHARMACEUTICAL CORP (US) | 2002-08-14 | — | — | EP | disclosed |
| EP-0935415-A1 | METHODS FOR DELIVERING COMPOUNDS INTO A CELL | IMARX PHARMACEUTICAL CORP. (US) | 1999-08-18 | — | — | EP | disclosed |
| WO-1997040679-A1 | METHODS FOR DELIVERING COMPOUNDS INTO A CELL | IMARX PHARMACEUTICAL CORP. (US) | 1997-11-06 | — | — | WO | disclosed |